Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APM NASDAQ:EQ NYSE:TMG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPMAptorum Group$0.94+1.3%$0.97$0.46▼$7.49$4.97M-0.17620,151 shs32,515 shsEQEquillium$0.35+0.5%$0.36$0.27▼$1.50$12.44M1.86466,224 shs248,584 shsTMG(TMG)$0.00$0.00▼$0.00N/AN/AN/A109,000 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPMAptorum Group+1.28%-1.89%-13.59%+19.24%-74.54%EQEquillium+0.52%+7.03%-9.33%-26.93%-52.18%TMG(TMG)0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPMAptorum Group2.081 of 5 stars0.05.00.00.03.81.70.6EQEquillium3.0084 of 5 stars3.24.00.00.03.11.70.6TMG(TMG)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPMAptorum Group 0.00N/AN/AN/AEQEquillium 2.33Hold$3.00757.14% UpsideTMG(TMG) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPMAptorum Group$430K11.72N/AN/A$2.20 per share0.43EQEquillium$41.10M0.30N/AN/A$0.54 per share0.65TMG(TMG)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPMAptorum Group-$4.27MN/A0.00∞N/AN/AN/AN/A7/30/2025 (Estimated)EQEquillium-$8.07M-$0.39N/AN/AN/A-19.62%-74.34%-46.75%8/6/2025 (Estimated)TMG(TMG)N/AN/A0.00N/AN/AN/AN/AN/AN/ALatest APM, TMMG, TMG, EQ, and MIRI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q1 2025EQEquillium-$0.1850N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPMAptorum GroupN/AN/AN/AN/AN/AEQEquilliumN/AN/AN/AN/AN/ATMG(TMG)N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPMAptorum GroupN/A0.220.22EQEquilliumN/A2.702.70TMG(TMG)N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPMAptorum Group3.80%EQEquillium27.05%TMG(TMG)N/AInsider OwnershipCompanyInsider OwnershipAPMAptorum Group63.99%EQEquillium31.60%TMG(TMG)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPMAptorum Group305.35 million1.93 millionNot OptionableEQEquillium4035.72 million24.43 millionNot OptionableTMG(TMG)N/AN/AN/ANot OptionableAPM, TMMG, TMG, EQ, and MIRI HeadlinesRecent News About These CompaniesMather Group Acquires $58M RIA FirmJune 10, 2022 | financialadvisoriq.comFLouisville wealth management firm acquired by Chicago companyJune 6, 2022 | bizjournals.comJohnny Depp Allowed "Whistleblower" in Business Manager Suit Despite "Perjury" ChallengeJune 3, 2022 | uk.news.yahoo.comWhere did all of Johnny Depp’s money go? From Ford Mustangs for Amber Heard to his lavish lifestyle and those lawsuits, the Pirates of the Caribbean star’s net worth was ...June 1, 2022 | msn.comCould quality and value be the key for shares in Mission?June 1, 2022 | uk.finance.yahoo.comExtension of Primaries: TMG knocks INEC over yielding to pressure from politiciansMay 30, 2022 | vanguardngr.comVINEC’s extension of party primaries’ deadline, worrisome – TMGMay 30, 2022 | sunnewsonline.comSXI International OOH Congress to be held in Zavidovo, Russia during Sept 15-18May 30, 2022 | media4growth.comMTMG Faults INEC for Extending Deadline for Conducting PrimariesMay 29, 2022 | thisdaylive.comTTMG tackles INEC over extension of party primaries’ deadlineMay 28, 2022 | tribuneonlineng.comT‘It’s worrisome’ — TMG tackles INEC for extending deadline of party primariesMay 28, 2022 | thecable.ngT2023: TMG condemns INEC extension of primaries’ deadline, delegates’ inducementMay 28, 2022 | dailypost.ngDGlobal Trimethylgallium (TMG) Market 2022 Research Strategies, Consumer Needs, Application and Specification by 2028May 27, 2022 | marketwatch.comLudwig reveals hesitations around his involvement in Creator Clash 2May 27, 2022 | dexerto.comDTMG Negotiates Sale of 232-Unit Apartment Community in Killeen, TexasMay 26, 2022 | rebusinessonline.comR$7.375 Million Sale of a 21-unit Community in Los Angeles, CA Arranged by The Mogharebi GroupMay 25, 2022 | finance.yahoo.comViva Expeditions Joins Flight Centre’s Independent Model Within The Travel Managers GroupMay 23, 2022 | scoop.co.nzSViva Expeditions joins Flight Centre's Independent Model within the Travel Managers GroupMay 23, 2022 | voxy.co.nzVTaylor Music Group Presents Celtic and Choral Arts Series for Piccolo Spoleto 2022May 22, 2022 | holycitysinner.comHA Jersey Guy: Where are the adults in CFB?May 20, 2022 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeAI Chip Arms Race: 3 Must-Watch Equipment StocksBy Chris Markoch | July 10, 2025View AI Chip Arms Race: 3 Must-Watch Equipment StocksCorrection Equals Opportunity in Domino’s Pizza StockBy Gabriel Osorio-Mazilli | July 6, 2025View Correction Equals Opportunity in Domino’s Pizza StockAPM, TMMG, TMG, EQ, and MIRI Company DescriptionsAptorum Group NASDAQ:APM$0.94 +0.01 (+1.28%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$0.96 +0.02 (+1.92%) As of 07/11/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.Equillium NASDAQ:EQ$0.35 +0.00 (+0.52%) Closing price 07/11/2025 03:40 PM EasternExtended Trading$0.35 0.00 (-0.86%) As of 07/11/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.(TMG) NYSE:TMGTaylor & Martin Group, Inc. provide marketplaces and value-added solutions for the liquidation of pre-owned capital assets, excess inventory and returned consumer goods. The Company's platform, which it refers to as its TMG Complete Solution, offers a range of services, including pre-owned capital assets, such as commercial trucks and trailers, agricultural, construction and industrial equipment, and excess inventory and returned consumer goods, such as footwear, apparel and accessories, electronics and general merchandise. It served these targeted markets through its two operating divisions: TMG Auction Services and TMG Reverse Logistics. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Plug Power’s 20% Surge Signals New Commercial Growth Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
